Watch this short video highlight to hear expert insights on the latest updates from AIDS 2020: Virtual on weight changes during ART and PrEP.
Patients switching from TDF to TAF in the OPERA cohort experienced an increase in weight of about 2 kg over 9 months, but then the rate of weight gain stabilized to be similar to the rate observed before the switch. How should these data inform ART decisions in clinical practice?
Since the introduction of daily oral FTC/TDF PrEP 8 years ago, new options have emerged and promising new data on investigational strategies that do not require daily oral dosing suggest that highly effective HIV prevention modalities will continue to expand. Here’s my take on new PrEP data from AIDS 2020: Virtual.
Hear insights from Chloe Orkin, MBChB, FRCP, MD, on some of the most important new data reported at AIDS 2020: Virtual, including the use of current ART regimens in principal populations, metabolic outcomes during ART, HIV and COVID-19, investigational ART strategies, and HIV prevention.
In this downloadable slideset, CCO’s expert faculty members summarize key studies from this important conference, including new data on the following hot topics: current ART in principal populations, including older patients and women who become pregnant; metabolic outcomes during ART; HIV and COVID-19; investigational ART strategies; and HIV prevention.